Latest News and Press Releases

Weinstein brings more than two decades of experience in life sciences leadership, venture capital, and company buildingProven track record of guiding innovative healthcare organizations from...

2026 soll für BioNTech ein Jahr mit zahlreichen wertrelevanten Meilensteinen (Katalysatoren) werden, unter anderem durch weitere Fortschritte bei Pipeline-Kandidaten, die sich bereits in der späten...

2026 poised to be a catalyst-rich year for BioNTech with continued late-stage pipeline progress with candidates across immunomodulators, antibody-drug conjugates and mRNA immunotherapiesExpected 2026...

The CDMO aseptic filling market size is booming, fueled by rising demand for sterile manufacturing and injectable therapies.

Scenic enters license and research agreement with Ono Pharmaceutical to utilize Scenic’s Cell-Seq platform for the discovery of novel therapeutics

ISELIN, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of...

BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...

Lunsumio VELO reduces administration time from 2-4 hours to approximately one minuteAvailability of Lunsumio VELO allows treatment aligned to people’s clinical needs and personal preferences Approval...

The monoclonal antibody discovery platform market covers manufacturers, suppliers, value chain and revenue forecasts. North America holds 35% share in 2024

BioNTech has completed its exchange offer to acquire CureVacAcquisition complements BioNTech’s capabilities and proprietary technologies in mRNA design, delivery formulations, and mRNA manufacturingIn...